All countries with a WHO office have a Country Cooperation Strategy (CCS). CCSs are flexible to align with the national health planning cycle (generally 4-5 years).

After the WHO country office and the government finalize the CCS, the country office develops a CCS Brief. The 2-page brief is updated each year, in advance of the World Health Assembly. It summarizes:

• the main features of the country context in relation to health, development and cooperation with partners;
• WHO’s main work priorities with the country in the medium term; and
• key public health indicators, utilizing data from the WHO Global Health Observatory

The present report, submitted in response to General Assembly resolution 67/299, provides a review of progress in the implementation of the resolution, focusing on the adoption and scaling-up of interventions recommended by WHO in malaria-endemic countries. It provides an assessment of progress towards the 2015 global malaria targets, including Millennium Development Goal 6, targets set through the African Union and the World Health Assembly and goals set through the Global Malaria Action Plan of the Roll Back Malaria Partnership. It elaborates on the challenges limiting the full achievement of the targets, and provides recommendations to ensure that progress is accelerated up to and beyond 2015.

Related documents

• General Assembly resolution 67/299 
  pdf, 77.8kb
• General Assembly resolution 68/308 
  pdf, 61.1kb

• WHO progress report on implementing UN General Assembly resolution 68/308 
• WHO progress report on implementing UN General Assembly resolution 66/289

Interim guidance: Rapid hospital readiness checklist: Interim Guidance

Todo comenzó hace unos años, cuando el TDR entrevistó a un conjunto de científicas a quienes había brindado apoyo en algún momento de su carrera, para conocer sus avances y trayectorias. Con este compendio, decidimos dar un paso adelante y entrevistar de nuevo a las integrantes del grupo original a fin de adentrarnos en su excepcional recorrido por el campo de la ciencia. Todas proceden de distintas naciones: Colombia, Ghana, Kenia, Malaui, Mali, Marruecos, Birmania, Nigeria, Pakistán, Filipinas, Somalia, Sudáfrica, Sudán, Suazilandia (Esuatini), Uganda, y el Reino Unido de Gran Bretaña y el Norte de Irlanda, por mencionar algunas.

This document summarizes the procedures of the WHO-FIND Malaria Rapid Diagnostic Test (RDT) Evaluation Programme regarding malaria RDT product testing and lot testing activities. It is intended to be a resource for both manufacturers and procurers who are or may wish to use these services to support quality control of malaria RDTs.

The purpose of this document is to provide specific and standardized procedures and guidelines for testing long-lasting insecticidal mosquito nets for personal protection and malaria control. It is intended to harmonize the testing procedures carried out to generate data for registration and labelling of such products by national authorities.

The Health EDRM Research Network is a collaborative mechanism between WHO and participants of the research network. The Health EDRM Research Network is not an independent legal entity. These Terms of Reference outline the governance aspects of the Health EDRM Research Network.

ntermittent preventive treatment in infancy (IPTi) is the administration of a full course of an effective antimalarial treatment to infants at risk of malaria at specified time points, regardless of whether or not they are parasitaemic, with the objective of reducing the infant malaria burden.

The protective efficacy of IPTi with sulfadoxine-pyrimethamine (IPTi-SP) is dependent upon the antimalarial efficacy of SP, to which there has been increasing parasite resistance in most parts of Africa. This is the report of a technical expert consultation convened by the Global Malaria Programme in Geneva, Switzerland on 10-11 September 2009 to identify the most appropriate marker(s) of SP resistance and their threshold levels that would be indicative of the protective efficacy of SP in IPTi, to guide the deployment of IPTi-SP in a given area.

Related document

• Intermittent preventive treatment for infants using sulfadoxine-pyrimethamine (IPTi-SP) for malaria control in Africa: implementation field guide (2011)

This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes. 

The aims are to improve capacity in critical synthesis and analysis of determinants of malaria transmission in low-endemic settings; increase understanding of health system components in order to assess the feasibility of national or sub-national malaria elimination; and plan strategies and approaches for sustained malaria elimination.

The module can be used both for in-service or pre-service training programmes. It uses a problem-solving approach to facilitate learning and promotes practical applications, involving individual and team work. 

• The Guide for participants covers basic concepts and information, and includes a series of exercises to be carried out by the participants.
• The Guide for tutors provides guidance for the facilitators as well as answers to the exercises.

Additional downloads

Supporting exercises: These files are necessary for participants to complete a number of exercises listed in the manual.

• Unit 2. Exercise 2.4 (xlsx, 16kb)
• Unit 5. Exercise 5.5 (ppt, 1.09Mb)
• Unit 8. ESP worksheets (xlsx, 306kb)
• Annex 2. Moshkovsky's method for determining the malaria season (xlsx, 34kb)

• Requisition form
  doc, 119kb

The Country Cooperation Strategy (CCS) is WHO’s strategic framework to guide the Organization’s work in and with a country. It responds to that country’s National Health and Development Agenda and identifies a set of agreed joint priorities for WHO collaboration, covering those areas where the Organization has a comparative advantage in order to assure public health impact.

The CCS is WHO’s corporate framework strategy to implement GPW13 with a response to country needs and priorities and addresses the Sustainable Development Agenda in health-related Sustainable Development Goals.

Cada vez es más frecuente que los organismos de las Naciones Unidas, otros organismos internacionales y las organizaciones no gubernamentales sean llamados a responder a emergencias de gran envergadura para prevenir y afrontar amenazas graves para la supervivencia y la salud de las poblaciones afectadas. Los organismos de socorro han venido proporcionando medicamentos y dispositivos médicos (material renovable y equipo) por décadas. El concepto del botiquín médico de emergencia ha sido adoptado por muchas organizaciones y autoridades nacionales como fuente fiable, estandarizada, asequible y de acceso inmediato de medicamentos esenciales y dispositivos médicos (material renovable y equipo) que se necesitan con urgencia en una situación de desastre. Su contenido se basa en las necesidades sanitarias de 10 000 personas durante un periodo de tres meses.

El Botiquín Médico Interinstitucional de Emergencia de 2011 (BMIE 2011, para abreviar) mejora el contenido de la versión anterior y tiene en cuenta la necesidad de atención de salud mental en circunstancias de emergencia, así como las necesidades especiales de los niños. El presente documento proporciona información básica sobre la composición y el uso del botiquín.

The objective of this document is to provide, in a format which is more accessible for field use, a summary of existing WHO information regarding the principles of identification and management of communicable diseases in malnourished populations. It addresses synergistic risk factors for communicable disease transmission and malnutrition, the prevention of morbidity and mortality due to communicable diseases in malnourished populations, and clinical considerations for the diagnosis and treatment of specific communicable diseases in malnourished patients.

The WHO Global Malaria Programme’s T3: Test. Treat. Track. initiative supports malaria-endemic countries in their efforts to achieve universal coverage with diagnostic testing and antimalarial treatment, as well as in strengthening their malaria surveillance systems. 

The initiative seeks to focus the attention of policy-makers and donors on the importance of adopting WHO’s latest evidence-based recommendations on diagnostic testing, treatment and surveillance, and on updating existing malaria control and elimination strategies, as well as country-specific operational plans.

More information on the T3 initiative

• T3: Test. Treat. Track initiative

The presence of oral artemisinin monotherapies in the market continues to represent a threat to the useful therapeutic life of these medicines, by encouraging the development of resistance. 

At the meeting, held in Geneva, Switzerland on 24 August 2007, seven new companies declared their willingness to stop marketing artemisinin monotherapies over a short period, increasing to 61.2% (41 out of 67) the proportion of companies willing to comply with WHO recommendations. 

People affected by humanitarian crises, particularly those displaced and/or living in camps and camp-like settings, are often faced with specific challenges and vulnerabilities that must be taken into consideration when planning for readiness and response operations for the COVID-19 outbreak. They are frequently neglected, stigmatized, and may face difficulties in accessing health services that are otherwise available to the general population. In the context of this Interim Guidance, the people in humanitarian situations affected by this guidance may include internally displaced persons (IDPs), host communities, asylum seekers, refugees and returnees, and migrants when in similar situations. While further adaptations might be needed for some population groups, including those living in slums this interim guidance is issued to assist field staff to immediately respond to urgent needs.

- Access the interim guidance